Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Elderly population needs new definition to inform treatment decisions

Dr Reinhard Stauder, Prof Mario Boccadoro
Elderly population needs new definition to inform treatment decisions ( Dr Reinhard Stauder, Prof Mario Boccadoro )
27 Nov 2013

Expert care is needed for elderly haematology patients

Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders Österborg
Expert care is needed for elderly haematology patients ( Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders Österborg )
27 Nov 2013

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer

Dr Jonathan Shamash - Barts Cancer Institute, London, UK
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash -  Barts Cancer Institute, London, UK )
15 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

ecancerNews November Round Up

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews November Round Up ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013

Editor’s Choice - ecancermedicalscience November 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor’s Choice - ecancermedicalscience November 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013

The future of CLL treatment: balancing efficacy, safety and cost

Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA
The future of CLL treatment: balancing efficacy, safety and cost ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )
14 Nov 2013

Making sense of the expanding armoury of treatment options for the less fit CLL patient

Dr Valentin Goede - Uniklinik Köln, Cologne, Germany
Making sense of the expanding armoury of treatment options for the less fit CLL patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )
14 Nov 2013

‘Go-Go’ CLL patients: a look towards the future

Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany
‘Go-Go’ CLL patients: a look towards the future ( Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
14 Nov 2013

The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer

Dr Daniel Rea - University of Birmingham, UK
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer ( Dr Daniel Rea - University of Birmingham, UK )
12 Nov 2013

PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer

Dr Chris Gallagher - Barts and the London NHS Trust, UK
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )
12 Nov 2013

Chemosaturation therapy for cancers in the liver

Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK
Chemosaturation therapy for cancers in the liver ( Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK )
11 Nov 2013